title: Increased erythropoietin levels as a biomarker of pancreatic adenocarcinoma: A case report.
abstract: Pancreatic cancer is one of the deadliest cancers commonly diagnosed at an advanced stage. Early diagnosis is crucial for the timely and potentially curative treatment of this highly fatal disease. Although screening tests have improved the survival rate in malignancies such as colon, breast, cervical and prostate cancer, there is currently no effective screening method available for the early detection of pancreatic cancer. As the sensitivity and specificity of existing biomarkers, such as carbohydrate antigen 19-9, for the early detection of pancreatic cancer is low, there is a pressing need for the identification of novel cancer markers. An increase in erythropoietin (EPO) levels has been observed in several cases of pancreatic neoplasms. However, the potential role of EPO as a biomarker of pancreatic cancer or malignant transformation requires further investigation. We herein present a case of increased EPO levels in an adult male patient with stage IV pancreatic cancer.
authors: Department of Internal Medicine, Raritan Bay Medical Center, Perth Amboy, NJ 07733, USA.
authors: Rafay
authors: R
authors: Khan
authors: Department of Internal Medicine, Raritan Bay Medical Center, Perth Amboy, NJ 07733, USA.
authors: Qiang
authors: Q
authors: Nai
authors: Department of Internal Medicine, Raritan Bay Medical Center, Perth Amboy, NJ 07733, USA.
authors: Ping
authors: P
authors: Zhang
authors: Department of Internal Medicine, Raritan Bay Medical Center, Perth Amboy, NJ 07733, USA.
authors: Hongxiu
authors: H
authors: Luo
authors: Department of Internal Medicine, Raritan Bay Medical Center, Perth Amboy, NJ 07733, USA.
authors: Shraman
authors: S
authors: Sen
authors: Department of Internal Medicine, Raritan Bay Medical Center, Perth Amboy, NJ 07733, USA.
authors: Ibrahim
authors: I
authors: Sidhom
authors: Department of Internal Medicine, Raritan Bay Medical Center, Perth Amboy, NJ 07733, USA.
authors: Teena
authors: T
authors: Mathew
authors: Department of Internal Medicine, Raritan Bay Medical Center, Perth Amboy, NJ 07733, USA.
authors: Mohammad
authors: M
authors: Islam
authors: Department of Internal Medicine, Raritan Bay Medical Center, Perth Amboy, NJ 07733, USA.
authors: Shuvendu
authors: S
authors: Sen
authors: Department of Internal Medicine, Raritan Bay Medical Center, Perth Amboy, NJ 07733, USA.
authors: Abdalla
authors: A
authors: Yousif
keywords: adenocarcinoma; erythropoietin; malignancy; pancreatic cancer